Neveen A Abdelaziz

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 6

Top Topics

Molecular Docking

Multidrug Resistant

Cystic Fibrosis

Top Venues

Antibiotics (Basel, Switzerland)

Infection and drug resistance

Antimicrobial resistance and infection control

This page only lists publications with an associated author ORCID identifier.

Publications

Sayed E El-Sayed, Neveen A Abdelaziz, Amer Al Ali, Mohammed Y Alshahrani, Khaled M A Aboshanab, Ghadir S El-Housseiny
Identification, Characterization, and Production Optimization of 6-Methoxy-1H-Indole-2-Carboxylic Acid Antifungal Metabolite Produced by Bacillus toyonensis Isolate OQ071612. Microorganisms 11 (12) (2023)
Sayed E El-Sayed, Neveen A Abdelaziz, Amer Al Ali, Mohammed Y Alshahrani, Khaled M A Aboshanab, Ghadir S El-Housseiny
Identification, Characterization, and Production Optimization of 6-Methoxy-1H-Indole-2-Carboxylic Acid Antifungal Metabolite Produced by Bacillus toyonensis Isolate OQ071612. Microorganisms 11 (12) (2023)
Neveen A Abdelaziz
Phenotype-genotype correlations among carbapenem-resistant Enterobacterales recovered from four Egyptian hospitals with the report of SPM carbapenemase. Antimicrobial resistance and infection control 11 (1) (2022)
Neveen A Abdelaziz, Walid F Elkhatib, Mahmoud M Sherif, Mohammad A S Abourehab, Sara T Al-Rashood, Wagdy M Eldehna, Nada M Mostafa, Nooran Sherif Elleboudy
In Silico Docking, Resistance Modulation and Biofilm Gene Expression in Multidrug-Resistant Acinetobacter baumannii via Cinnamic and Gallic Acids. Antibiotics (Basel, Switzerland) 11 (7) (2022)
Sayed E El-Sayed, Neveen A Abdelaziz, Hosam-Eldin Hussein Osman, Ghadir S El-Housseiny, Ahmed M Elissawy, Khaled M A Aboshanab
Lysinibacillus Isolate MK212927: A Natural Producer of Allylamine Antifungal 'Terbinafine'. Molecules (Basel, Switzerland) 27 (1) (2021)
Sayed E El-Sayed, Ghadir S El-Housseiny, Neveen A Abdelaziz, Mona R El-Ansary, Khaled M Aboshanab
Optimized Production of the Allylamine Antifungal "Terbinafine" by Lysinibacillus Isolate MK212927 Using Response Surface Methodology. Infection and drug resistance 13 (2020)